Free Trial

FibroBiologics (FBLG) SEC Filings & 10K Form

FibroBiologics logo
$2.81 -0.27 (-8.77%)
(As of 11/14/2024 ET)

Recent FibroBiologics SEC Filings

DateFilerForm TypeView
09/24/2024
3:01 PM
FibroBiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2024
3:01 PM
FibroBiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024
6:47 PM
Cilento Richard C. Jr. (Reporting)
FibroBiologics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
6:51 PM
Coen Stacy Ann (Reporting)
FibroBiologics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
6:53 PM
FibroBiologics (Issuer)
Hoffman Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
6:54 PM
FibroBiologics (Issuer)
Link Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
6:55 PM
FibroBiologics (Issuer)
Niklas Victoria Ninon Olivia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
3:01 PM
FibroBiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
11:15 PM
FibroBiologics (Filer)
Form EFFECT
08/12/2024
8:57 PM
FibroBiologics (Issuer)
Khoja Hamid (Reporting)
Form 3/A
08/12/2024
8:58 PM
FibroBiologics (Issuer)
O'HEERON PETE (Reporting)
Form 3/A
08/12/2024
8:58 PM
FibroBiologics (Issuer)
Khoja Hamid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
8:58 PM
FibroBiologics (Issuer)
O'HEERON PETE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
4:21 PM
FibroBiologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/08/2024
10:23 AM
FibroBiologics (Filer)
Form DEF 14A
07/08/2024
10:25 AM
FibroBiologics (Filer)
Form DEFA14A
07/08/2024
10:27 AM
FibroBiologics (Filer)
Form ARS
06/27/2024
4:16 PM
FibroBiologics (Filer)
Form PRE 14A
06/27/2024
6:22 AM
FibroBiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2024
5:11 AM
FibroBiologics (Filer)
Form 424B4
06/25/2024
11:15 PM
FibroBiologics (Filer)
Form EFFECT
06/06/2024
9:58 AM
FibroBiologics (Filer)
Form RW
06/04/2024
1:36 PM
FibroBiologics (Filer)
Form S-1/A
05/14/2024
3:05 PM
FibroBiologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2024
7:56 AM
FibroBiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
11:15 PM
FibroBiologics (Filer)
Form EFFECT
03/26/2024
4:28 PM
FibroBiologics (Filer)
Form S-1/A
03/15/2024
3:09 PM
FibroBiologics (Filer)
Form S-1/A
02/29/2024
4:09 PM
FibroBiologics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/20/2024
8:57 AM
FibroBiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2024
8:01 PM
FibroBiologics (Issuer)
Niklas Victoria Ninon Olivia (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/13/2024
5:28 PM
FibroBiologics (Issuer)
Link Matthew (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/13/2024
5:30 PM
Coen Stacy Ann (Reporting)
FibroBiologics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/12/2024
4:18 PM
FibroBiologics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
02/08/2024
8:27 PM
FibroBiologics (Issuer)
Khoja Hamid (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/08/2024
6:32 PM
FibroBiologics (Issuer)
O'HEERON PETE (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/08/2024
11:15 AM
FibroBiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2024
6:40 PM
Cilento Richard C. Jr. (Reporting)
FibroBiologics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/07/2024
6:45 PM
FibroBiologics (Issuer)
Hoffman Robert E. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/07/2024
4:56 PM
Andersen Mark C. (Reporting)
FibroBiologics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/06/2024
3:52 PM
FibroBiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
The next assassination attempt won’t be on Trump (Ad)

President Trump is soon to be back in the White House. Unity has been restored to the U.S. But if you watched the President’s 25-minute victory speech, you probably noticed he spent nearly four minutes speaking about one very controversial person.

I share with you in this special investigative documentary.
02/01/2024
8:04 PM
FibroBiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2024
8:45 PM
FibroBiologics (Filer)
Form 424B4
01/30/2024
12:20 PM
FibroBiologics (Filer)
Form CERT
01/24/2024
11:15 PM
FibroBiologics (Filer)
Form EFFECT
01/24/2024
2:36 PM
FibroBiologics (Filer)
Form S-1/A
01/24/2024
10:11 AM
FibroBiologics (Filer)
Form 8-A12B
01/22/2024
3:14 PM
FibroBiologics (Filer)
Form S-1/A
01/12/2024
3:05 PM
FibroBiologics (Filer)
Form S-1/A
12/14/2023
3:36 PM
FibroBiologics (Subject)
Form FWP
12/07/2023
3:28 PM
FibroBiologics (Filer)
Form S-1/A
12/04/2023
8:15 AM
FibroBiologics (Filer)
Form S-1/A
11/30/2023
3:44 PM
FibroBiologics (Filer)
Form S-1/A
11/27/2023
7:16 PM
FibroBiologics (Filer)
Form S-1/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:FBLG) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners